INTRODUCTION {#sec1-1}
============

Bronchial asthma is one of the most common diseases affecting the children worldwide.\[[@ref1]\] Several observational studies suggest that serum Vitamin D deficiency is also common in children.\[[@ref2][@ref3][@ref4]\] Vitamin D is an immunomodulator\[[@ref5]\] and Vitamin D receptors (VDRs) are present in cells of the immune system such as macrophages, dendritic cells, monocytes, and activated T- and B-cells.\[[@ref6]\] VDRs regulate the transcription of various genes implicated in inflammation and immunomodulation of respiratory epithelium.\[[@ref7]\] Vitamin D suppresses the proinflammatory cytokines interleukin-17 (IL-17) and IL-13 and promotes the anti-inflammatory cytokines such as IL-10. Further, Vitamin D shifts the balance of T lymphocyte response from Th1 phenotype to Th2 phenotype.\[[@ref8][@ref9]\] Studies on Vitamin D and asthma in children had mixed results. The low maternal 25-hydroxyvitamin D (25(OH)D) levels\[[@ref10][@ref11]\] and low cord blood 25(OH)D levels\[[@ref12]\] had been associated with increased risk of early childhood wheezing. However, in another study, higher Vitamin D levels during pregnancy were associated with increased risk of eczema at age of 9 months and asthma at age of 9 years in offspring.\[[@ref13]\] Vitamin D deficiency has been associated with increased incidence\[[@ref14]\] and severity\[[@ref15]\] of childhood asthma. A few observational studies suggested association between low serum Vitamin D levels and poor asthma control and reduced lung function in children.\[[@ref15][@ref16][@ref17]\] Whereas some other studies had adverse effects of Vitamin D in asthma.\[[@ref13][@ref18]\] In a study, Vitamin D supplementation during 1^st^ year of life was associated with higher prevalence of allergic rhinitis, atopy, and asthma at age of 31 years of life.\[[@ref18]\] The question of whether or not Vitamin D deficiency is a risk factor for pediatric asthma needs to be clarified. We conducted a systematic review and meta-analysis to evaluate the prevalence of Vitamin D deficiency in asthmatic children and to determine the correlation between Vitamin D levels and asthma incidence, asthma control, and lung functions in children.

MATERIALS AND METHODS {#sec1-2}
=====================

We searched the literature from PubMed, EMBASE, and Cochrane Library. The PubMed database was searched using MeSh terms for asthma and Vitamin D without any filters. The EMBASE database was searched with keywords "'vitamin d'/exp and 'asthma'/exp" without any filter. The Cochrane Library was searched with keywords "asthma" and "vitamin d" in title and abstract without any other filter. The last search for PubMed, EMBASE, and Cochrane was repeated on July 27, 2015. Reference list of eligible studies was hand searched for additional studies.

Inclusion criteria {#sec2-1}
------------------

Type of studies: Observational studies - cross-sectional studies, case--control studies, and cohort studies; population - children up to 18 years of age; content of study - related to asthma and Vitamin D.

Exclusion criteria {#sec2-2}
------------------

Randomized controlled trials (RCTs) assessing effect of Vitamin D supplementation on asthma as this was not the objective of the reviewStudies comparing maternal serum level of Vitamin D with incidence of asthma in children.

The outcome measures of review were (1) mean Vitamin D levels among asthmatic and nonasthmatic children; (2) prevalence of Vitamin D deficiency and insufficiency among asthmatic and nonasthmatic children; and (3) relation between Vitamin D levels and incidence, lung functions, and control of asthma in children. Serum 25(OH)D levels of \<20 ng/ml, between 20 and 30 ng/ml, and levels of 30--40 ng/ml are defined as Vitamin D deficient, Vitamin D insufficient, and Vitamin D sufficient levels in the review based on previously published studies, respectively.\[[@ref19][@ref20][@ref21][@ref22]\] Prevalence of Vitamin D deficiency and insufficiency was assessed using these definitions. Definition of incidence, lung functions, and asthma control were used as described by included studies.

Two authors independently assessed the title and abstract of electronic search results for potential eligible studies. The full texts of potential eligible studies were obtained and studies were selected for inclusion in the review as per inclusion criteria above. Two authors independently retrieved data in a predefined data collection proforma.

Quality assessment methods {#sec2-3}
--------------------------

The Newcastle--Ottawa Scale\[[@ref23]\] (NOS) was used for assessing quality of nonrandomized studies (cohort and case--control studies).

Statistical methods {#sec2-4}
-------------------

We analyzed dichotomous outcomes by calculating odds ratio (OR). Continuous outcome data were analyzed as mean differences (MDs). We presented overall results with 95% confidence intervals (CIs). Meta-analysis was performed using Cochrane RevMan 5.1. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2011.\[[@ref24]\] Meta-analysis was only performed on studies of similar design and outcome measures and that comparison of different study types and outcomes are simply presented in the text.

The review was performed as per preferred reporting items for systematic reviews and meta-analyses statement for reporting systematic reviews and meta-analyses wherever applicable.

RESULTS {#sec1-3}
=======

Study selection {#sec2-5}
---------------

The flow diagram for study selection is shown in [Figure 1](#F1){ref-type="fig"}. The electronic database search revealed a total of 1822 records. Sixty potential eligible studies were identified after screening for titles and abstracts of all records. Full texts of 60 potential eligible studies were assessed for final inclusion in the review. One additional study was identified by reviewing references of included studies. Thirty-eight studies were excluded as per the reasons given in [Figure 1](#F1){ref-type="fig"} and remaining 23 studies were included in the review.

![Study selection flow diagram](LI-34-355-g001){#F1}

Included studies {#sec2-6}
----------------

The data extractions from 23 included studies are shown in Tables [1](#T1){ref-type="table"}--[3](#T3){ref-type="table"}. There were 11 case--control studies\[[@ref16][@ref25][@ref26][@ref27][@ref28][@ref29][@ref30][@ref31][@ref32][@ref33][@ref34]\] \[[Table 1](#T1){ref-type="table"}\], 5 cohort studies\[[@ref9][@ref14][@ref35][@ref36][@ref37]\] \[[Table 2](#T2){ref-type="table"}\], and 7 cross-sectional studies\[[@ref1][@ref5][@ref38][@ref39][@ref40][@ref41][@ref42][@ref43]\] \[[Table 3](#T3){ref-type="table"}\]. A total of 13,160 subjects were enrolled in included studies: Case--control studies, 2979; cohort studies, 7830; and cross-sectional studies, 2351. Included studies were both from developed and developing countries: USA (*n* = 4), Italy (*n* = 2), Turkey (*n* = 2), one each from UK, Qatar, China, Tunisia, Iran, USA, Costa Rica, Egypt, The Netherlands, Australia, New Zealand, Canada, Germany, and Thailand. Origin of country was not known for a few studies where only conference abstracts were available.

###### 

Case--control studies for asthma and Vitamin D in children

![](LI-34-355-g002)

###### 

Cohort studies for asthma and Vitamin D in children

![](LI-34-355-g003)

###### 

Cross-sectional studies for asthma and Vitamin D in children

![](LI-34-355-g004)

Quality of studies {#sec2-7}
------------------

Assessment of quality of case--control and cohort studies using NOS is shown in last row of Tables [1](#T1){ref-type="table"} and [2](#T2){ref-type="table"}, respectively. A majority of studies were of moderate to high quality.

Outcomes {#sec2-8}
--------

Meta-analysis of included studies was performed using Review Manager and results are shown in [Table 4](#T4){ref-type="table"} and Figures [2](#F2){ref-type="fig"}--[4](#F4){ref-type="fig"}. There was significant heterogeneity among studies; therefore, random effect model was used for meta-analysis.

###### 

Meta-analysis of Vitamin D levels in asthmatic and nonasthmatic children

![](LI-34-355-g005)

![Forest plot of comparison of mean 25-hydroxyvitamin D levels in asthmatic and nonasthmatic children](LI-34-355-g006){#F2}

![Forest plot of proportion of asthmatic and nonasthmatic children with Vitamin D deficiency and insufficiency](LI-34-355-g007){#F3}

![Forest plot of proportion of asthmatic and nonasthmatic children with Vitamin D sufficiency](LI-34-355-g008){#F4}

### Mean Vitamin D levels among asthmatic and nonasthmatic children {#sec3-1}

Mean 25(OH)D levels were available from 10 case--control studies enrolling 2383 participants. Five studies\[[@ref25][@ref27][@ref29][@ref31][@ref34]\] had significantly lower mean 25(OH)D levels in asthmatic children as compared to nonasthmatic children \[[Figure 2](#F2){ref-type="fig"}\]. In other five studies,\[[@ref19][@ref26][@ref28][@ref30][@ref33]\] mean 25(OH)D levels were not different between the groups. After pooling data from the 10 studies, the mean 25(OH)D levels were significantly lower in asthmatic children as compared to nonasthmatic children with MD of −9.41 (95% CI −16.57, −2.25) \[[Table 4](#T4){ref-type="table"} and [Figure 2](#F2){ref-type="fig"}\].

### Prevalence of Vitamin D deficiency and insufficiency among asthmatic and nonasthmatic children {#sec3-2}

Vitamin D status was extracted from cohort and case--control studies. Prevalence of Vitamin D deficiency and insufficiency varied markedly between different studies ranging from 3.4% to 77.4% and 4.1% to 85.8%, respectively \[Tables [1](#T1){ref-type="table"} and [3](#T3){ref-type="table"}\]. Overall, on an average, 28.5% and 26.7% children were Vitamin D deficient and insufficient, respectively.

Data regarding proportion of children having Vitamin D deficiency among asthmatic versus nonasthmatic children were available from eight case--control studies enrolling 1795 patients. After pooling data, OR of asthmatic children being Vitamin D deficient (levels \<20 ng/ml) was 3.41 (95% CI 2.04, 5.69) \[[Table 4](#T4){ref-type="table"} and [Figure 3](#F3){ref-type="fig"}\]. OR of asthmatic children having Vitamin D levels below 30 ng/ml (after combining subjects with both insufficiency and deficiency) was 2.34 (95% CI 1.23, 4.43) \[[Table 4](#T4){ref-type="table"} and [Figure 3](#F3){ref-type="fig"}\].

Children without asthma had Vitamin D levels more sufficient as compared to asthmatic children \[[Figure 4](#F4){ref-type="fig"}\].

### Relation between Vitamin D levels and incidence of asthma {#sec3-3}

Four cohort studies reported relation of Vitamin D levels with incidence and prevalence. van Oeffelen *et al*.\[[@ref14]\] assessed relation between serum micronutrient concentrations including Vitamin D and prevalence of asthma in children and found that there was inverse associations between serum Vitamin D concentrations and asthma and severe asthma at age of 4 years with OR of 0.49, 95% CI: 0.25--0.95, although there was no association between serum Vitamin D concentrations and severe asthma at 8 years of age in the same study.\[[@ref14]\] Camargo *et al*.\[[@ref9]\] assessed association between cord blood Vitamin D levels and respiratory outcome at 5 years of age and found that there was increased incidence of cumulative wheezing (OR \[95% CI\] = 1.63 \[1.17, 2.26\] and 2.15 \[1.39, 3.33\]) for insufficiency and deficiency, respectively, as compared to sufficiency at 5 years of age but there was no association between cord blood Vitamin D levels and incidence of asthma at 5 years of age with OR of 1.19 (95% CI 0.78, 1.83) and 0.94 (95% CI 0.53, 1.64) for insufficiency and deficiency as compared to sufficiency, respectively.\[[@ref9]\] In a West Australian pregnancy cohort study by Hollams *et al*.,\[[@ref36]\] asthma at age of 14 years was not related to Vitamin D levels with OR of 0.39 \[95% CI 0.09, 1.62; *P* = 0.1930\].

### Relation between Vitamin D levels and lung functions {#sec3-4}

Five studies\[[@ref26][@ref16][@ref31][@ref39][@ref43]\] reported significant association between Vitamin D levels and lung functions in asthmatic children including forced expiratory volume in 1 s (FEV~1~),\[[@ref16][@ref26][@ref31][@ref39][@ref43]\] FEV~1~/forced vital capacity (FVC),\[[@ref31][@ref39][@ref43]\] bronchodilator response,\[[@ref26]\] and exercise-induced bronchoconstriction\[[@ref16]\] in asthmatic children. On the other side, there was no correlation between Vitamin D levels and FEV~1~ and FEV~1~/FVC in asthmatic children in the study by Brehm *et al*.,\[[@ref15]\] Maalmi *et al*.,\[[@ref30]\] Wu *et al*.,\[[@ref35]\] Chinellato *et al*.,\[[@ref38]\] Krobtrakulchai,\[[@ref41]\] and Neagu.\[[@ref42]\]

### Relation between Vitamin D levels and control of asthma in children {#sec3-5}

A few studies reported correlation of Vitamin D levels with asthma control. A positive relationship was found between 25(OH)D level and childhood asthma control in the study by Gupta *et al*.\[[@ref26]\] (*r* = 0.6, *P* = 0.001), Chinellato *et al*.,\[[@ref38]\] and Uysalol *et al*.\[[@ref34]\] No association between Vitamin D levels and asthma control was reported in study by Menon *et al*.,\[[@ref28]\] Krobtrakulchai,\[[@ref41]\] and Neagu.\[[@ref42]\] Daily doses of inhaled steroids were inversely related to serum Vitamin D levels in the study by Brehm *et al*.,\[[@ref15]\] Gupta *et al*.,\[[@ref26]\] and Searing *et al*.,\[[@ref39]\] but there was no association between Vitamin D levels and inhaled steroid doses in the study by Krobtrakulchai\[[@ref41]\] Brehm *et al*.,\[[@ref32]\] Gupta *et al*.,\[[@ref26]\] and Wu *et al*.\[[@ref35]\] Uysalol *et al*.\[[@ref34]\] reported association between increased acute asthma exacerbations and lower serum 25(OH)D levels, but again no association between Vitamin D levels and asthma exacerbation in the study by Krobtrakulchai\[[@ref41]\] and Neagu.\[[@ref42]\] No associations were reported between Vitamin D level and eosinophil counts, duration of disease, and the number of hospitalization or unscheduled visits in a year (*P* \> 0.05) by Alyasin *et al*.\[[@ref31]\] Four studies\[[@ref25][@ref26][@ref29][@ref43]\] evaluated association between Vitamin D levels and total IgE in asthmatic children and found inverse correlation.

DISCUSSION {#sec1-4}
==========

This systematic review of 23 observational studies found that mean Vitamin D levels were significantly lower in asthmatic children compared to nonasthmatic children, but correlation between Vitamin D levels with incidence/prevalence of asthma, lung functions, and control of asthma was not uniform among the studies. Wide range of Vitamin D deficiency may be explained by variation in nutritional status, difference in sun exposure, fortification of food items, use of supplements, geographical location of country, and many other factors in different countries. Vitamin D deficiency and asthma may be linked by reverse causation because Vitamin D is synthesized by sun exposure and it is likely that asthmatic children may spend less time outdoor due to sickness by asthma. Brehm *et al*.\[[@ref32]\] evaluated correlation between Vitamin D levels and asthma exacerbations in children after adjusting for time spent outdoors and racial ancestry and found that there was still a strong association between Vitamin D deficiency and asthma exacerbations after adjusting these factors. Therefore, this reverse causation seems to be less plausible. A recent review of observational studies by Cassim *et al*.\[[@ref44]\] included both children and adult patients and identified 23 studies (12 cohort, 9 cross-sectional, and 2 case--control studies) and reported that higher Vitamin D levels were associated with decreased risk of acute exacerbations of asthma. Similar to our review, they also reported mixed results for association of Vitamin D levels with prevalence, incidence, and severity of asthma.\[[@ref44]\] This review also included studies where Vitamin D levels were measured during pregnancy.\[[@ref44]\] We excluded such studies, therefore number of cohort studies were less in our review. Yadav and Mittal\[[@ref45]\] conducted a randomized controlled trial of oral Vitamin D3 (cholecalciferol) supplementation of 60,000 IU per month for 6 months in children and reported better peak expiratory flow rate improvement, better asthma control, and reduced need of emergency visit and oral steroids use in Vitamin D group compared to placebo group. However, the Vitamin D levels were not measured in the study.\[[@ref45]\] In another pediatric RCT, 500 units of Vitamin D supplementation daily for 6 months showed decreased asthma exacerbation in Vitamin D group though Vitamin D levels did not change before and after supplementation and lung function improved significantly in both arms.\[[@ref46]\] The Vitamin D assessment (VIDA) trial randomized 408 adults with poorly controlled asthma to supplement with high-dose Vitamin D or placebo.\[[@ref47]\] Vitamin D supplementation did not alter the rate of first treatment failure during 28 weeks. In a subgroup analysis, subjects with a rise in Vitamin D levels \>30 ng/ml had decreased rate of treatment failure and acute asthma exacerbations compared to placebo.\[[@ref47]\] These trials suggest that Vitamin D supplementation will not be of help in all asthmatic children but in certain group of children.

Strength of the review includes broad search strategy, rigorous data extraction, and analysis. There are some limitations of review. First, we could not find full text of seven included studies (three case--control and four cross-sectional studies). Second, there was significant heterogeneity among included studies. Vitamin D levels were measured by different methods in different studies, e.g., radioimmunoassay method in Brehm *et al*.,\[[@ref15]\] Chinellato *et al*.,\[[@ref16]\] Bener *et al*.,\[[@ref25]\] Maalmi *et al*.,\[[@ref30]\] Alyasin *et al*.,\[[@ref31]\] and Wu *et al*.;\[[@ref35]\] enzyme-linked immunosorbent assay in van Oeffelen *et al*.,\[[@ref14]\] Freishtat *et al*.,\[[@ref27]\] and Hollams *et al*.;\[[@ref36]\] high-performance liquid chromatography system--tandem mass spectrometry in Gupta *et al*. 2011;\[[@ref26]\] and chemiluminescence immunoassay by Camargo *et al*.,\[[@ref9]\] Chinellato *et al*.,\[[@ref38]\] and Searing *et al*.\[[@ref39]\] Finally, VIDA levels at different ages, diagnosis of asthma at variable ages, and partial control for confounders in some studies make results of the review difficult to rely upon. Large randomized clinical trials of Vitamin D supplementation with emphasis on timing and dosage are needed before recommending Vitamin D to children with asthma. It may be possible that Vitamin D supplementation may be beneficial in selected children who are Vitamin D deficient and dosages are sufficient enough to raise Vitamin D levels to normal range. It would be helpful if could identify asthmatic children who will benefit from Vitamin D supplementation in a particular dose for a particular duration.

CONCLUSIONS {#sec1-5}
===========

Prevalence of Vitamin D deficiency varied from country to country. Asthmatic children had significantly lower Vitamin D levels as compared to nonasthmatic children. Correlation between Vitamin D levels and incidence of asthma, lung functions, and control of asthma had mixed results. There is need of large well-conducted randomized trials of Vitamin D supplementation with different doses and different duration of supplementation to assess the efficacy of Vitamin D on lung function and asthma control in children.

Note {#sec2-9}
----

The abstract was presented at the International Congress of Pediatrics 2013 (ICP), the 27^th^ Congress of International Pediatric Association, held at Melbourne, Australia, from 24-29 August 2013.
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